Introduction {#sec1}
============

While melanoma represents the deadliest form of skin cancer, reported cases of metastasis to the bladder are rare, with just 29 confirmed cases reported in English-language literature. This number is likely an underestimation of the true burden of disease, as autopsy series of patients with metastatic melanoma have found an 18%--37% rate of metastatic disease to the bladder.[@bib1], [@bib2] Nonetheless, metastatic disease that presents in the bladder is rare and poses a significant challenge in diagnosis and management. We report a case that highlights such challenges and review literature on metastatic melanoma with a focus on bladder metastases.

Case presentation {#sec2}
=================

A 49-year-old Caucasian woman presented to the dermatology clinic for follow-up of her malignant melanoma with a complaint of painless gross hematuria. Two years prior she was diagnosed with malignant melanoma from a skin lesion on her left flank. She had a wide excision with negative margins and a negative axillary sentinel lymph node biopsy. The pathology confirmed stage IIC (7 mm thickness, Clark level IV) malignant melanoma and she received 3000 cGy of adjuvant radiotherapy to the left flank. The patient had no evidence of disease until her presentation with hematuria. A computed tomography (CT) scan demonstrated two enhancing lesions in the bladder, with the largest one measuring 33 mm in largest diameter along the left posterolateral bladder wall ([Fig. 1](#fig1){ref-type="fig"}A). Voided urine cytology identified cells that expressed S-100, HMB-45, and Melan-A, consistent with malignant melanoma ([Fig. 2](#fig2){ref-type="fig"}). Cystoscopy demonstrated a large nodular mass with brown pigmentation on the left trigone as well as multiple discontinuous nodular lesions on the left lateral wall ([Fig. 1](#fig1){ref-type="fig"}B). Although the remainder of her abdominal/pelvic CT was free of visible disease, a more thorough metastatic survey was completed, and brain magnetic resonance imaging demonstrated frontal and occipital lobe lesions consistent with metastatic disease. Given the multiple sites of metastatic disease, we felt the patient was not likely to derive a survival benefit from metastasectomy, which for complete resection in the location of her trigone would likely require cystectomy. She was treated conservatively with stereotactic body radiation therapy (SBRT) of the brain metastases, systemic therapy with checkpoint inhibitor combination therapy of nivolumab and ipilimumab, and cystoscopic intervention planned for episodes of intractable hematuria.

Discussion {#sec3}
==========

Malignant melanoma is the deadliest skin cancer in the United States with over 67,000 new cases per year and an estimated 30% will eventually develop metastases.[@bib3] While the majority of metastatic spread occurs to skin, lungs, liver, and brain, metastasis to the bladder in clinical series appear to be rare with only 29 reported cases in the literature ([Table 1](#tbl1){ref-type="table"}). This in contrast to autopsy series which indicate an 18%--37% incidence of metastatic disease in the bladder.[@bib1], [@bib2] The most common presenting symptom is hematuria, and isolated metastatic disease to the bladder is relatively rare. The confirmation of metastatic melanoma is made possible through immunohistochemical analysis demonstrating characteristic expression of S-100, HMB-45, MART-1/Melan-A, tyrosinase, and MITF.

Once metastatic, treatment options are limited and survival is generally poor, reflecting a lack of effective systemic therapies. Chemotherapeutics have limited effect on survival, however the introduction of immunotherapy has been promising in select cases. Interleukin-2 therapy was introduced in the late 1990s but with a low response rate and significant side effects including an inflammatory response syndrome that often limits treatment. Targeted therapies in the form of BRAF, MEK, KIT, VEGF pathway inhibitors have improved response rates, but not durably. More recent use of checkpoint inhibitors including antibodies targeting PD-1 or PD-L1 and CTLA4 are promising due to higher response rates and a chance of durable response.[@bib4]

Location of the initial metastatic site appears to be a significant predictor of survival with improved survival for skin metastases, and progressively lower survival associated with distant nodal involvement, gastrointestinal, lung, bone, liver, and brain metastasis. Given the few cases of bladder metastases reported in the literature, it is not clear if this location portends a worse outcome.

The question for urologists dealing with metastatic melanoma to the bladder is: does surgery play a role in the management, and if so, should management be transurethral resection (TUR) or cystectomy? Similar to genitourinary malignancies, metastasectomy for malignant melanoma is controversial, but retrospective data suggests metastasectomy may be associated with improved overall survival compared to systemic therapy alone.[@bib5] The role of metastasectomy in the era of newer effective systemic agents is likely to be answered in future studies, but at present, a multidisciplinary team of surgeons, radiation oncologists, and medical oncologists should jointly devise a treatment strategy. In the other reported cases of metastatic melanoma to the bladder, treatment varied from observation, transurethral resection, and even cystectomy. The choice of surgical strategy should be based on overall prognosis, the patient\'s health status, presence of local symptoms attributable to bladder metastases, invasiveness of approach, and quality of life factors. Bladder metastases resulting in hematuria and voiding symptoms that can sometimes be managed by TUR, however TUR may not be sufficient to remove the entire tumor in many cases. Obviously, radical cystectomy or partial cystectomy for metastatic disease represents a markedly aggressive step compared to TUR, and such cases should probably be limited to those with solitary or limited metastatic disease and favorable prognostic factors. Unfortunately, our patient had concomitant brain metastasis and we felt there was limited evidence she would benefit from more invasive surgery. We elected to administer SBRT for her brain lesions, offer systemic therapy with combined checkpoint inhibitor immunotherapy, and manage her bladder metastasis conservatively. Growing evidence suggests the efficacy of SBRT in melanoma, despite previous consideration that this tumor was 'radioresistant,' and possible synergistic effects of radiation with immunotherapy, the so-called 'abscopal effect.'

Conclusion {#sec4}
==========

Reported cases of metastatic melanoma to the bladder are rare. While long-term survival of patients with metastatic melanoma is rare, evolving treatment strategies and increasing acceptance of a survival benefit to metastasectomy in certain settings poses significant challenges to management. Integrating urologic treatments into a multidisciplinary strategy is important in managing these patients.
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![Panel A. Axial section CT abdomen/pelvis with IV and oral contrast demonstrating a left posterolateral bladder wall-enhancing lesion measuring 33 mm in largest diameter. Panel B. Cystoscopy reveals large nodular mass (∼3 cm) with brown pigmentation at left posterolateral wall of bladder as well as satellite lesions.](gr1){#fig1}

![Cytologic assessment of voided urine demonstrating malignant melanoma diagnosis. Panel A. Malignant cells with fine, brown melanin pigment (H&E stain, ×400). Panel B. Immunohistochemical stain positive for HMB-45 (red chromogen, ×400). Panel C. Immunohistochemical stain positive for S-100 (brown chromogen, ×400).](gr2){#fig2}
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Review of English-language literature of metastatic melanoma to the bladder.

Table 1

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Authors, Journal (year), Pubmed ID                                                Age and gender    Presenting symptom                                       Synchronous metastasis                                  Treatment                                                            Survival
  --------------------------------------------------------------------------------- ----------------- -------------------------------------------------------- ------------------------------------------------------- -------------------------------------------------------------------- ------------------------------------
  Amar, Journal of Urology (1964), 14213534                                         33yo Male         Hematuria                                                Maxillary lesions                                       Partial cystectomy                                                   NR

  Bartone, Journal of Urology, (1964), 14118110                                     70yo Female       Hematuria                                                Lymph nodes                                             Partial cystectomy                                                   Died within 2 months

  Weston and Smith, British Journal of Surgery, (1964), 14103391                    69yo Male         Urinary retention                                        Widespread                                              None                                                                 Died 5 days after diagnosis

  Dasgupta and Grabstald, Journal of Urology (1965), 14290417                       2 patients\       A. Hematuria\                                            A. Axillary lesion\                                     A. Transurethral fulguration\                                        A. Died within 4 months\
                                                                                    A. 35yo Male\     B. Hematuria                                             B. Inguinal nodes                                       B. Tumor cryotherapy and partial cystectomy                          B. NR
                                                                                    B. 35yo Female                                                                                                                                                                                          

  Meyer, Cancer (1974), 4426038                                                     3 patients\       A. Incidental\                                           A. Widespread\                                          A. Chemotherapy\                                                     A. NR\
                                                                                    A. 69yo Male\     B. Hematuria\                                            B. Unknown\                                             B. Partial cystectomy\                                               B. Died 16 months after resection\
                                                                                    B. 60yo Female\   C. Incidental                                            C. Lungs                                                C. TUR                                                               C. Died 2 months after resection
                                                                                    C. 42yo Male                                                                                                                                                                                            

  Silverstein et al, JAMA (1974), 4408302                                           56yo Male         Hematuria                                                Lymph nodes                                             Intratumor injection of BCG vaccine followed by partial cystectomy   Alive at 8 month follow-up

  Tolley et al, British Journal of Clinical Practice (1975), 1191491                48yo Female       Hematuria                                                Absent                                                  Radical cystectomy                                                   NR

  Chin et al, Journal of Urology (1982), 7062434                                    70yo Female       Hematuria, voiding, symptoms, suprapubic pain, fatigue   Bowel                                                   Partial cystectomy\                                                  NR
                                                                                                                                                                                                                       Colectomy                                                            

  Stein and Kendall, Journal of Urology (1984), 6387180                             50yo Male         Hematuria                                                Absent                                                  TUR chemotherapy                                                     Alive at 2 year follow-up

  Arapantoni-Dadioti et al, European Journal of Surgical Oncology (1995), 7851567   28yo Female       Dysuria                                                  Brain\                                                  Incomplete TUR                                                       2 months after resection
                                                                                                                                                               Lungs\                                                                                                                       
                                                                                                                                                               Lymph nodes                                                                                                                  

  Ergen at al, International Journal of Urology & Nephrology (1995), 8775037        65yo Male         Hematuria\                                               Renal pelvis\                                           Biopsy                                                               Died within 1 week
                                                                                                      Flank pain                                               Stomach                                                                                                                      

  Demiksesen et al, Urologia Internationalis (2000), 10810279                       45yo Female       Hematuria, urinary frequency                             Widespread                                              TUR chemotherapy                                                     NR

  Lee et al, Urology (2003), 12893353                                               46yo Male         Hematuria                                                Widespread                                              TUR and high-dose IL-2 immunotherapy                                 NR

  Martinez-Giron, Cytopathology (2008), 18713248                                    49yo Male         Hematuria                                                NR                                                      NR                                                                   NR

  Efesoy and Cayan, Medical Oncology (2011), 21042956                               60yo Female       Hematuria weight loss                                    Lungs                                                   TUR                                                                  Died 7 months after resection

  Nair et al, Journal of Clinical Oncology (2011), 21189399                         54yo Male         Hematuria                                                Widespread including ureteral and renal pelvic tumors   TUR and laser ablation of ureteral and renal pelvic tumors\          Died within 3 months of TURBT
                                                                                                                                                                                                                       Chemotherapy                                                         

  Charfi et al, Case Reports Pathology (2012), 23133774                             54yo Male         Unknown                                                  Lymph nodes                                             TUR                                                                  Died within 1 month

  Paterson et al, Central European Journal of Urology (2012), 24578971              84yo Male         Incidental                                               No other metastatic lesions                             None                                                                 NR

  Wisenbaugh et al, Current Urology (2012), 24917713                                4 patients\       A. Hematuria and voiding symptoms\                       A. Solidary\                                            A. TUR\                                                              A. Alive at 10 months\
                                                                                    A. 81yo Male\     B. Incidental\                                           B. Small bowel\                                         B. TUR\                                                              B. Died at 4 months\
                                                                                    B. 84yo Male\     C. Hematuria\                                            C. Widespread\                                          C. TUR\                                                              C. Died within 4 months\
                                                                                    C. 85yo Male\     D. Incidental                                            D. Lymph node small bowel widespread                    D. TUR                                                               D. Died within 5 months
                                                                                    D. 62yo Female                                                                                                                                                                                          

  Rishi et al, International Journal of Surgical Pathology (2014), 23794493         61yo Female       Hematuria\                                               Brain\                                                  TUR\                                                                 Died with 2 months
                                                                                                      dysuria                                                  Lung\                                                   Brain radiotherapy\                                                  
                                                                                                                                                               Skin                                                    High-dose interferon\                                                
                                                                                                                                                                                                                       Temozolomide                                                         

  Meunier et al, Case Reports Pathology (2015), 26106499                            55yo Female       Hematuria                                                Liver\                                                  Checkpoint inhibitor                                                 NR
                                                                                                                                                               Spleen\                                                                                                                      
                                                                                                                                                               Lung                                                                                                                         

  Shukla et al, Journal Endourology Case Reports (2016), 27579421                   60yo Male         Hematuria                                                Widespread                                              TUR                                                                  Alive at 1 year follow-up

  Current report                                                                    49yo Female       Hematuria                                                Brain                                                   Brain SBRT, checkpoint inhibitors                                    \-
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

TUR--transurethral resection; SBRT--stereotactic body radiotherapy; NR--not reported.
